𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5146 Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease – a meta-analysis of randomized controlled trials

✍ Scribed by Mauri, D.; Valachis, A.; Tsali, L.; Polyzos, N.P.; Casazza, G.

Book ID
123314509
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
64 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Do adjuvant aromatase inhibitors increas
Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer : Meta-analysis of randomized trials
✍ Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version